Rx Innovation: A Discussion on Biosimilars, Patient Access & Affordability

Event Horizontal


As government and industry leaders look to rein in the cost of healthcare, The Hill and Express Scripts will convene a forward-looking conversation on biosimilar drugs and how they could affect healthcare access and affordability.

Go to top